PATENT CLAIM ANALYSIS

Application Number: 16382824
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "259300"]

Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Claim (Index 51):
The method of  claim 48  wherein the disorder is an inflammatory disorder.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 100.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16382869', '16382680', '15457657', '13939816', '15789588']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8424206184701923
- 35 USC 102 Novelty (BERT): 0.5401678451596863
- Combined Prediction Score: 0.8121953411391417
- Mean Citation Score: 377.300258
- Max Citation Score: 444.15955
- Similarity Product: 192.27934819155345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test